Sifan Wu

1.6k total citations
19 papers, 160 citations indexed

About

Sifan Wu is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Nephrology. According to data from OpenAlex, Sifan Wu has authored 19 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Immunology and 5 papers in Nephrology. Recurrent topics in Sifan Wu's work include Vasculitis and related conditions (13 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Sifan Wu is often cited by papers focused on Vasculitis and related conditions (13 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Sifan Wu collaborates with scholars based in China. Sifan Wu's co-authors include Lindi Jiang, Xiufang Kong, Lili Ma, Rongyi Chen, Huiyong Chen, Ying Sun, Qingrong Huang, Zongfei Ji, Lingying Ma and Xiaomeng Cui and has published in prestigious journals such as PLANT PHYSIOLOGY, International Journal of Molecular Sciences and Lara D. Veeken.

In The Last Decade

Sifan Wu

18 papers receiving 158 citations

Peers

Sifan Wu

PRM

IMMUN

RHEUM

NEPHR

Yusuke Ebana Japan

Nilüfer Alpay Kanıtez Türkiye

Natsuko Tamura Japan

Joyce Wei Ting Goh United Kingdom

Iwona Kobielusz‐Gembala Poland

Mari Kamiya Japan

Rouchelle Sriranjan United Kingdom

Sawsan M. Jalalah Saudi Arabia

Mariana Luís Portugal

Julien Rohmer France

Yusuke Ebana Japan

Sifan Wu

83 ×1.1

PRM

38 ×0.7

IMMUN

37 ×1.1

RHEUM

40 ×1.3

37 ×1.3

NEPHR

Citations per year, relative to Sifan Wu Sifan Wu (= 1×) peers Yusuke Ebana

Countries citing papers authored by Sifan Wu

Since Specialization

Citations

This map shows the geographic impact of Sifan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sifan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sifan Wu more than expected).

Fields of papers citing papers by Sifan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sifan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sifan Wu. The network helps show where Sifan Wu may publish in the future.

Co-authorship network of co-authors of Sifan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sifan Wu. A scholar is included among the top collaborators of Sifan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sifan Wu. Sifan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wang, Xiaojie, Rui Li, Sifan Wu, et al.. (2025). LACCASE35 enhances lignification and resistance against Pseudomonas syringae pv. actinidiae infection in kiwifruit. PLANT PHYSIOLOGY. 197(2). 4 indexed citations

Xu, Jin, et al.. (2025). Biocontrol efficiency and the functional mechanisms of Bacillus velezensis RT-30 against kiwifruit soft rot. Horticultural Plant Journal. 3 indexed citations

Wu, Sifan, Bing Wu, Lingying Ma, et al.. (2025). Association of PET vascular activity score with Takayasu’s arteritis angiographic progression. European Journal of Nuclear Medicine and Molecular Imaging. 52(11). 4268–4280. 1 indexed citations

Ji, Zongfei, Weiqi Lu, Sifan Wu, et al.. (2023). Single-Cell RNA-Sequencing Reveals Peripheral T Helper Cells Promoting the Development of IgG4-Related Disease by Enhancing B Cell Activation and Differentiation. International Journal of Molecular Sciences. 24(18). 13735–13735. 6 indexed citations

Wu, Sifan, et al.. (2023). Scalable single-step synthesis of α-Nb2O5@C@Ti3C2 composite as high power and long life anode material for sodium-ion batteries. Journal of Solid State Electrochemistry. 29(1). 61–69. 4 indexed citations

Sun, Ying, Xiaomeng Cui, Xiufang Kong, et al.. (2023). The role of plateletcrit in Takayasu arteritis: A potential biomarker for disease activity and 6‐month treatment response. International Journal of Rheumatic Diseases. 26(12). 2517–2525. 1 indexed citations

Chen, Rongyi, et al.. (2022). Augmented PFKFB3-mediated glycolysis by interferon-γ promotes inflammatory M1 polarization through the JAK2/STAT1 pathway in local vascular inflammation in Takayasu arteritis. Arthritis Research & Therapy. 24(1). 266–266. 31 indexed citations

Kong, Xiufang, Sifan Wu, Ying Sun, et al.. (2022). A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis. Arthritis Research & Therapy. 24(1). 49–49. 10 indexed citations

Sun, Ying, Lingying Ma, Li Wang, et al.. (2022). A novel molecular mechanism of vascular fibrosis in Takayasu arteritis: macrophage-derived GPNMB promoting adventitial fibroblast extracellular matrix production in the aorta. Translational research. 255. 128–139. 15 indexed citations

10.

Ma, Lingying, Sifan Wu, Xuejuan Jin, et al.. (2022). Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study. Seminars in Arthritis and Rheumatism. 55. 152018–152018. 19 indexed citations

11.

Zhang, Xiao, Li Wang, Sifan Wu, et al.. (2022). Biomarker Changes and Molecular Signatures Associated with Takayasu Arteritis Following Treatment with Glucocorticoids and Tofacitinib. Journal of Inflammation Research. Volume 15. 4395–4407. 3 indexed citations

12.

Wang, Yujiao, Lili Ma, Ying Sun, et al.. (2022). Risk factors of aortic regurgitation progression in Chinese patients with Takayasu’s arteritis: a prospective cohort study. Therapeutic Advances in Chronic Disease. 13. 374175813–374175813.

13.

Sun, Ying, Sifan Wu, Yujiao Wang, et al.. (2021). Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension. Arthritis Research & Therapy. 23(1). 196–196. 3 indexed citations

14.

Wu, Sifan, Xiufang Kong, Xiaomeng Cui, et al.. (2021). Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population. Joint Bone Spine. 88(5). 105186–105186. 8 indexed citations

15.

Wu, Sifan, Xiufang Kong, Ying Sun, et al.. (2021). FABP3 overexpression promotes vascular fibrosis in Takayasu’s arteritis by enhancing fatty acid oxidation in aorta adventitial fibroblasts. Lara D. Veeken. 61(7). 3071–3081. 17 indexed citations

16.

Chen, Rongyi, Li Jiang, Sifan Wu, et al.. (2021). Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis. Modern Rheumatology. 31(6). 1135–1141. 3 indexed citations

17.

Wu, Chunling, Ying Sun, Xiaomeng Cui, et al.. (2020). Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis. Therapeutic Advances in Chronic Disease. 11. 1754267009–1754267009. 17 indexed citations

18.

Li, Weijun, Xingming Chen, Ya‐Jung Cheng, et al.. (2014). Early diagnostic and prognostic utility of high‐sensitive troponin assays in acute myocardial infarction: a meta‐analysis. Internal Medicine Journal. 45(7). 748–756. 14 indexed citations

19.

Wu, Sifan, et al.. (2007). Catheter ablation of haemodynamically unstable or non-sustained ventricular tachycardia. Acta Cardiologica. 62(2). 163–169. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact